Macrogenics (MGNX) Inventory Average (2021 - 2026)
Macrogenics (MGNX) reported Inventory Average of $8.7 million for Q1 2026, up 4.49% quarter-over-quarter from $8.3 million in Q4 2025.
Macrogenics (MGNX) Inventory Average (2021 - 2026) Analysis & Trends
Macrogenics (MGNX) has 6 years of Inventory Average data on file, last reported at $8.7 million in Q1 2026.
- Inventory Average for Q1 2026 came in at $8.7 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $8.7 million (changed N/A YoY), and the FY2023 annual result was $1.3 million, down 54.24% from the prior year.
- Inventory Average grew to $8.7 million in Q1 2026 per MGNX's latest filing, from $8.3 million in the prior quarter.
- Over five years, Inventory Average peaked at $9.3 million in Q2 2025 and troughed at $1.1 million in Q4 2023.
- A 5-year average of $3.8 million and a median of $2.0 million in 2022 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2022 and 2025: Inventory Average slumped 69.68% in 2022, then soared 690.31% in 2025.
- A 5-year view of Inventory Average shows it stood at $1.3 million in 2022, then fell by 9.85% to $1.1 million in 2023, then surged by 90.6% to $2.2 million in 2024, then soared by 282.2% to $8.3 million in 2025, then grew by 4.49% to $8.7 million in 2026.
- Business Quant data shows MGNX's Inventory Average at $8.7 million in Q1 2026, $8.3 million in Q4 2025, and $9.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.59 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.73 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Macrogenics | 260.14 Mn | 193.63 Mn | - | 8.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.70 Mn |
| Dec 31, 2025 | 8.33 Mn |
| Sep 30, 2025 | 9.01 Mn |
| Jun 30, 2025 | 9.34 Mn |
| Sep 30, 2024 | 2.18 Mn |
| Jun 30, 2024 | 1.18 Mn |
| Mar 31, 2024 | 1.23 Mn |
| Dec 31, 2023 | 1.14 Mn |
| Sep 30, 2023 | 1.25 Mn |
| Jun 30, 2023 | 1.43 Mn |
| Mar 31, 2023 | 1.43 Mn |
| Dec 31, 2022 | 1.27 Mn |
| Sep 30, 2022 | 2.02 Mn |
| Jun 30, 2022 | 3.77 Mn |
| Mar 31, 2022 | 4.49 Mn |
| Dec 31, 2021 | 4.18 Mn |
| Sep 30, 2021 | 5.23 Mn |
| Jun 30, 2021 | 6.32 Mn |